No Data
No Data
Morgan Stanley Keeps Their Hold Rating on BioNTech SE (BNTX)
European Equities Traded in the US as American Depositary Receipts Climb Higher in Friday Trading
European equities traded in the US as American depositary receipts were higher late Friday morning, rising 1.39% to 1,473.10 on the S&P Europe Select ADR Index. The index is set to end the week
Unusual Options Activity: CCK, PDD and Others Attract Market Bets, CCK V/OI Ratio Reaches 415.8
EST Jul 11th Morning Delivery - In the last two hours of trading, 8 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.19% to 1,460.27 on the S&P Europe Select ADR Index.From continental
CureVac Announced The Latest Trial Dates For Its Ongoing Patent Litigation Against Pfizer/BioNTech In Multiple Geographies, Including The U.S., UK, And Germany
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics. First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology)
Express News | CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech